247 related articles for article (PubMed ID: 17325653)
1. The 'specific' tyrosine kinase inhibitor genistein inhibits the enzymic hydrolysis of anandamide: implications for anandamide uptake.
Thors L; Alajakku K; Fowler CJ
Br J Pharmacol; 2007 Apr; 150(7):951-60. PubMed ID: 17325653
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the cellular uptake of anandamide by genistein and its analogue daidzein in cells with different levels of fatty acid amide hydrolase-driven uptake.
Thors L; Eriksson J; Fowler CJ
Br J Pharmacol; 2007 Nov; 152(5):744-50. PubMed ID: 17676056
[TBL] [Abstract][Full Text] [Related]
3. Does the hydrolysis of 2-arachidonoylglycerol regulate its cellular uptake?
Fowler CJ; Ghafouri N
Pharmacol Res; 2008 Jul; 58(1):72-6. PubMed ID: 18675915
[TBL] [Abstract][Full Text] [Related]
4. Involvement of fatty acid amide hydrolase and fatty acid binding protein 5 in the uptake of anandamide by cell lines with different levels of fatty acid amide hydrolase expression: a pharmacological study.
Björklund E; Blomqvist A; Hedlin J; Persson E; Fowler CJ
PLoS One; 2014; 9(7):e103479. PubMed ID: 25078278
[TBL] [Abstract][Full Text] [Related]
5. Lack of selectivity of URB602 for 2-oleoylglycerol compared to anandamide hydrolysis in vitro.
Vandevoorde S; Jonsson KO; Labar G; Persson E; Lambert DM; Fowler CJ
Br J Pharmacol; 2007 Jan; 150(2):186-91. PubMed ID: 17143303
[TBL] [Abstract][Full Text] [Related]
6. Biochanin A, a naturally occurring inhibitor of fatty acid amide hydrolase.
Thors L; Burston JJ; Alter BJ; McKinney MK; Cravatt BF; Ross RA; Pertwee RG; Gereau RW; Wiley JL; Fowler CJ
Br J Pharmacol; 2010 Jun; 160(3):549-60. PubMed ID: 20590565
[TBL] [Abstract][Full Text] [Related]
7. Selective inhibition of anandamide cellular uptake versus enzymatic hydrolysis--a difficult issue to handle.
Fowler CJ; Tiger G; Ligresti A; López-Rodríguez ML; Di Marzo V
Eur J Pharmacol; 2004 May; 492(1):1-11. PubMed ID: 15145699
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of fatty acid amide hydrolase by kaempferol and related naturally occurring flavonoids.
Thors L; Belghiti M; Fowler CJ
Br J Pharmacol; 2008 Sep; 155(2):244-52. PubMed ID: 18552875
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of fatty acid amide hydrolase and monoacylglycerol lipase by the anandamide uptake inhibitor VDM11: evidence that VDM11 acts as an FAAH substrate.
Vandevoorde S; Fowler CJ
Br J Pharmacol; 2005 Aug; 145(7):885-93. PubMed ID: 15895107
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation.
Fegley D; Gaetani S; Duranti A; Tontini A; Mor M; Tarzia G; Piomelli D
J Pharmacol Exp Ther; 2005 Apr; 313(1):352-8. PubMed ID: 15579492
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterization of endocannabinoid transport and fatty acid amide hydrolase inhibitors.
Dickason-Chesterfield AK; Kidd SR; Moore SA; Schaus JM; Liu B; Nomikos GG; Felder CC
Cell Mol Neurobiol; 2006; 26(4-6):407-23. PubMed ID: 16736384
[TBL] [Abstract][Full Text] [Related]
12. Measurement of saturable and non-saturable components of anandamide uptake into P19 embryonic carcinoma cells in the presence of fatty acid-free bovine serum albumin.
Sandberg A; Fowler CJ
Chem Phys Lipids; 2005 Apr; 134(2):131-9. PubMed ID: 15784231
[TBL] [Abstract][Full Text] [Related]
13. Involvement of N-acylethanolamine-hydrolyzing acid amidase in the degradation of anandamide and other N-acylethanolamines in macrophages.
Sun YX; Tsuboi K; Zhao LY; Okamoto Y; Lambert DM; Ueda N
Biochim Biophys Acta; 2005 Oct; 1736(3):211-20. PubMed ID: 16154384
[TBL] [Abstract][Full Text] [Related]
14. The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition.
Scherma M; Medalie J; Fratta W; Vadivel SK; Makriyannis A; Piomelli D; Mikics E; Haller J; Yasar S; Tanda G; Goldberg SR
Neuropharmacology; 2008 Jan; 54(1):129-40. PubMed ID: 17904589
[TBL] [Abstract][Full Text] [Related]
15. The endocannabinoid anandamide is a precursor for the signaling lipid N-arachidonoyl glycine by two distinct pathways.
Bradshaw HB; Rimmerman N; Hu SS; Benton VM; Stuart JM; Masuda K; Cravatt BF; O'Dell DK; Walker JM
BMC Biochem; 2009 May; 10():14. PubMed ID: 19460156
[TBL] [Abstract][Full Text] [Related]
16. Effects of the FAAH inhibitor, URB597, and anandamide on lithium-induced taste reactivity responses: a measure of nausea in the rat.
Cross-Mellor SK; Ossenkopp KP; Piomelli D; Parker LA
Psychopharmacology (Berl); 2007 Feb; 190(2):135-43. PubMed ID: 17111174
[TBL] [Abstract][Full Text] [Related]
17. Characterisation of (R)-2-(2-Fluorobiphenyl-4-yl)-N-(3-Methylpyridin-2-yl)Propanamide as a Dual Fatty Acid Amide Hydrolase: Cyclooxygenase Inhibitor.
Gouveia-Figueira S; Karlsson J; Deplano A; Hashemian S; Svensson M; Fredriksson Sundbom M; Congiu C; Onnis V; Fowler CJ
PLoS One; 2015; 10(9):e0139212. PubMed ID: 26406890
[TBL] [Abstract][Full Text] [Related]
18. Correlating FAAH and anandamide cellular uptake inhibition using N-alkylcarbamate inhibitors: from ultrapotent to hyperpotent.
Nicolussi S; Chicca A; Rau M; Rihs S; Soeberdt M; Abels C; Gertsch J
Biochem Pharmacol; 2014 Dec; 92(4):669-89. PubMed ID: 25283614
[TBL] [Abstract][Full Text] [Related]
19. Fatty acid amide hydrolase inhibition heightens anandamide signaling without producing reinforcing effects in primates.
Justinova Z; Mangieri RA; Bortolato M; Chefer SI; Mukhin AG; Clapper JR; King AR; Redhi GH; Yasar S; Piomelli D; Goldberg SR
Biol Psychiatry; 2008 Dec; 64(11):930-7. PubMed ID: 18814866
[TBL] [Abstract][Full Text] [Related]
20. The endogenous cannabinoid anandamide produces delta-9-tetrahydrocannabinol-like discriminative and neurochemical effects that are enhanced by inhibition of fatty acid amide hydrolase but not by inhibition of anandamide transport.
Solinas M; Tanda G; Justinova Z; Wertheim CE; Yasar S; Piomelli D; Vadivel SK; Makriyannis A; Goldberg SR
J Pharmacol Exp Ther; 2007 Apr; 321(1):370-80. PubMed ID: 17210800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]